How many milliliters of sterile normal saline should be added to a 40 mg/mL triamcinolone (triamcinolone acetonide) solution to obtain a 10 mg/mL preparation, and how should the resulting solution be injected sub‑dermally along the upper and lower incision lines?

Dilution and Injection Protocol for Triamcinolone 40 mg/mL to 10 mg/mL

To dilute 40 mg/mL triamcinolone acetonide to 10 mg/mL, add 3 mL of sterile normal saline to each 1 mL of the 40 mg/mL solution, then inject the diluted solution subdermally along the incision lines using multiple small-volume injections.

Dilution Calculation

The dilution follows a straightforward ratio:

• Starting concentration: 40 mg/mL
• Target concentration: 10 mg/mL
• Dilution ratio: 1:4 (1 part triamcinolone to 3 parts saline)

For every 1 mL of 40 mg/mL triamcinolone, add 3 mL of sterile normal saline to achieve 4 mL total volume at 10 mg/mL 1.

Injection Technique

Inject 0.05-0.1 mL of the diluted 10 mg/mL solution at multiple points spaced 0.5-1.0 cm apart along both the upper and lower incision lines. Each injection delivers approximately 0.5-1.0 mg of triamcinolone and will produce a small area of effect about 0.5 cm in diameter 2.

Key Technical Points:

• Depth: Inject just beneath the dermis in the upper subcutis—not intradermal, not deep subcutaneous 2
• Volume per site: 0.05-0.1 mL per injection point
• Spacing: 0.5-1.0 cm between injection sites
• Needle gauge: 25-30 gauge needle for subdermal placement
• Technique: Use strict aseptic technique; shake vial before drawing to ensure uniform suspension 3

Clinical Context and Rationale

The 10 mg/mL concentration is the standard recommended dose for inflammatory lesions and scar prevention 1. This concentration balances efficacy with safety—higher concentrations (40 mg/mL) are reserved specifically for established hypertrophic scars and keloids, not prophylactic incision line treatment 1.

The guideline explicitly states that triamcinolone acetonide at 10 mg/mL may be further diluted with sterile normal saline to 5 or 3.3 mg/mL if needed, but 10 mg/mL represents the standard starting concentration for most inflammatory conditions 1.

Critical Safety Considerations

Avoid These Complications:

• Skin atrophy: The most common adverse effect from local overdose. Using 10 mg/mL instead of 40 mg/mL significantly reduces this risk 1
• Pigmentary changes and telangiectasias: Result from excessive local concentration 1
• Impaired wound healing: Can occur with any corticosteroid injection near incision sites 1

Contraindications:

Do not inject if:

• Active infection present at the site (impetigo, herpes) 1
• Previous hypersensitivity to triamcinolone 1
• Patient has uncontrolled diabetes, as even local injections can affect glucose control 1

Preparation Protocol

1. Shake the 40 mg/mL vial thoroughly to ensure uniform suspension 3
2. Draw up the required volume of triamcinolone 40 mg/mL
3. Add 3 mL sterile normal saline for every 1 mL of triamcinolone drawn
4. Mix thoroughly but gently
5. Inject immediately after preparation to prevent settling 3

Example Calculation:

• If you need 4 mL of 10 mg/mL solution:
  • Draw 1 mL of 40 mg/mL triamcinolone
  • Add 3 mL sterile normal saline
  • Total volume = 4 mL at 10 mg/mL concentration
  • Total triamcinolone dose = 40 mg

Expected Outcomes

When properly administered at 10 mg/mL concentration:

• Onset: Effects typically visible within 48-72 hours 1
• Duration: Approximately 9 months of effect 2
• Success rate: 62% achieve desired response with appropriate dosing 2

The evidence strongly supports using the 10 mg/mL concentration for prophylactic scar management along incision lines rather than the undiluted 40 mg/mL formulation, which carries substantially higher risk of local tissue atrophy 1, 2, 4.